Cytek Biosciences Reports Second Quarter 2022 Financial Resu

10.08.2022 - Second quarter revenue grew 32% compared to prior yearFREMONT, Calif., Aug. 10, 2022 (GLOBE NEWSWIRE) - Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported financial results for the second quarter ended June 30, ...

Related Keywords

China , Fremont , California , United States , Wenbin Jiang , Stephanie Olsen , Pauld Goodson , Cytek Bioscience , Cytek Biosciences , Exchange Commission , Cytek Biosciences Inc , Linkedin , Twitter , European Union , Securities Exchange , Lages Associates , Full Spectrum Profiling , Northern Lights , Regarding Use , Private Securities Litigation Reform Act , Securities Act , Securities Exchange Act , Cytek Bioscience Annual Report , Cytek Bioscience Quarterly Report , Relations Contact , Month Ended June , Income Taxes ,